title: Identification of the activator-binding residues in the second cysteine-rich regulatory domain of protein kinase Cθ (PKCθ).
abstract: PKC (protein kinase C) θ is predominantly expressed in T-cells and is critically involved in immunity. Design of PKCθ-selective molecules to manage autoimmune disorders by targeting its activator-binding C1 domain requires the knowledge of its structure and the activator-binding residues. The C1 domain consists of twin C1 domains, C1A and C1B, of which C1B plays a critical role in the membrane translocation and activation of PKCθ. In the present study we determined the crystal structure of PKCθC1B to 1.63 Å (1 Å=0.1 nm) resolution, which showed that Trp(253) at the rim of the activator-binding pocket was orientated towards the membrane, whereas in PKCδC1B the homologous tryptophan residue was orientated away from the membrane. This particular orientation of Trp(253) affects the size of the activator-binding pocket and the membrane affinity. To further probe the structural constraints on activator-binding, five residues lining the activator-binding site were mutated (Y239A, T243A, W253G, L255G and Q258G) and the binding affinities of the PKCθC1B mutants were measured. These mutants showed reduced binding affinities for phorbol ester [PDBu (phorbol 12,13-dibutyrate)] and diacylglycerol [DOG (sn-1,2-dioctanoylglycerol), SAG (sn-1-stearoyl 2-arachidonyl glycerol)]. All five full-length PKCθ mutants exhibited reduced phorbol-ester-induced membrane translocation compared with the wild-type. These results provide insights into the PKCθ activator-binding domain, which will aid in future design of PKCθ-selective molecules.
authors.affiliation: Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
authors.forename: Ghazi M
authors.initials: GM
authors.lastname: Rahman
authors.forename: Sreejesh
authors.initials: S
authors.lastname: Shanker
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Lewin
authors.forename: Noemi
authors.initials: N
authors.lastname: Kedei
authors.forename: Colin S
authors.initials: CS
authors.lastname: Hill
authors.forename: B V Venkataram
authors.initials: BV
authors.lastname: Prasad
authors.forename: Peter M
authors.initials: PM
authors.lastname: Blumberg
authors.forename: Joydip
authors.initials: J
authors.lastname: Das
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D001665:Binding Sites; D020536:Enzyme Activators / Q000737:chemistry* / Q000378:metabolism; D007527:Isoenzymes / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D020125:Mutation, Missense; D011493:Protein Kinase C / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000074121:Protein Kinase C-theta; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D014364:Tryptophan / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
chemical_list: D020536:Enzyme Activators; D007527:Isoenzymes; D014364:Tryptophan; C489593:Prkcq protein, mouse; D011493:Protein Kinase C; D000074121:Protein Kinase C-theta